News
Cite this: Adenomyosis: new knowledge is generating new treatment strategies - Medscape - May 01, 2009.
In March, we announced that Focal One received CE Mark approval for the treatment of posterior deep infiltrating endometriosis. And in April we launched the new Focal One Eye Robotic HIFU system ...
Currently, there is a single case report of pregnancy following treatment of focal uterine adenomyosis, a relatively uncommon indication for the procedure. 1 We report the first case of a ...
As previously mentioned, they calculated a prevalence of diffuse and focal adenomyosis in 79% of all patients with endometriosis; this reached 90% in women younger than 36 years, a prevalence of ...
LYON, France, November 19, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced a moderated scientific presentation of clinical data comparing Focal ...
News provided by EDAP TMS S.A. Nov 19, 2024, 8:00 AM ET ...
As previously reported, the Company’s ongoing Phase 3 trial evaluating Focal One HIFU for the treatment of deep infiltrating endometriosis continues per protocol, with more than 85% of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results